Despite a large prospective study recently suggesting that HbA1c is effective as a screening tool for cystic fibrosis related diabetes (CFRD), a group of Australian experts have warned against its widespread use for now. In April this year a study published in the Journal of Cystic Fibrosis showed that at a cut off level of ...
Experts caution against using HbA1c as a screening tool in CF
By Jennie James
12 Nov 2015